Effect of medication and psychotherapy on heart rate variability in panic disorder

Depression and Anxiety

Volumn 26, Issue 3, 2009, Pages 251-258

  Garakani, Amir ^a,d   Martinez, Jose M ^a   Aaronson, Cindy J ^a   Voustianiouk, Andrei ^b   Kaufmann, Horacio ^b   Gorman, Jack M ^c  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Univ S Carolina Sch Med Vice P   (United States)

^d MOUNT SINAI HOSPITAL   (United States)

Author keywords

Anxiety; Breathing; Cardiac; Cognitive behavioral therapy; Life stress; SSRI

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HEART RATE VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PANIC; PATIENT ASSESSMENT; PRIORITY JOURNAL; PSYCHOTHERAPY; SUPINE POSITION; TREATMENT DURATION;

ADOLESCENT; ADULT; AGED; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG ADMINISTRATION SCHEDULE; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE; HUMANS; LIFE CHANGE EVENTS; MALE; MIDDLE AGED; PANIC DISORDER; PSYCHOTHERAPY; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; YOUNG ADULT;

EID: 63849218052     PISSN: 10914269     EISSN: 15206394     Source Type: Journal    
DOI: 10.1002/da.20533     Document Type: Article

References (57)

1. Kessler RC, Chiu WT, Jin R et al. The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2006;63:415-424.
2. Mitte K. A meta-analysis of the efficacy of psycho- and pharmacotherapy in panic disorder with and without agoraphobia. J Affect Disord 2005; 88:27-45.
3. Barlow DH, Gorman JM, Shear MK, Woods SW. Cognitive- behavioral therapy, imipramine, or their combination for panic disorder. A randomized controlled trial. JAMA 2000;283: 2529-2536.
4. Bruce SE, Vasile RG, Goisman RM et al. Are benzodiazepines still the medication of choice for patients with panic disorder with or without agoraphobia? Am J Psychiatry 2003;160: 1432-1438.
5. Goisman RM, Warshaw MG, Keller MB. Psychosocial treatment prescriptions for generalized anxiety disorder, panic disorder, and social phobia, 1991-1996. Am J Psychiatry 1999; 156:1819-1821.
6. Coryell W, Noyes R, Clancy J. Excess mortality in panic disorder: a comparison with primary unipolar depression. Arch Gen Psychiatry 1982;39:701-703.
7. Haines AP, Imeson JD, Meade TW. Phobic anxiety and ischaemic heart disease. Br Med J (Clin Res Ed) 1987;295: 297-299.
8. Weissman M, Markowitz JS, Ouellette R et al. Panic disorder and cardiovascular/cerebrovascular problems: results from a community survey. Am J Psychiatry 1990;147:1504-1508.
9. Gomez-Caminero A, Blumentals WA, Russo LJ et al. Does panic disorder increase the risk of coronary heart disease? A cohort study of a national managed care database. Psychosom Med 2005; 67:688-691.
10. Kawachi I, Sparrow D, Vokonas PS. Symptoms of anxiety and risk of coronary heart disease: the Normative Aging Study. Circulation 1994; 90:2225-2229.
11. Smoller JW, Pollack MH, Wassertheil-Smoller S et al. Panic attacks and risk of incident cardiovascular events among postmenopausal women in the Women's Health Initiative Observational Study. Arch Gen Psychiatry 2007;64:1153-1160.
12. Kleiger RE, Miller JP, Bigger JT, Moss AJ. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 1987;59:256-262.
13. Molgaard H, Sorensen KE, Bjerregaard P. Attenuated 24-hr heart rate variability in apparently healthy subjects, subsequently suffering sudden cardiac death. Clin Auton Res 1991;1:233-237.
14. Bigger JT, Fleiss JL, Steinman RC et al. Frequency domain measures of heart period variability and mortality after myocar- dial infarction. Circulation 1992;85:164-171.
15. Bigger JT, Fleiss JL, Steinman RC et al. Correlations among time and frequency domain measures of heart period variability two weeks after acute myocardial infarction. Am J Cardiol 1992;69:891-898.
16. Tsuji H, Larson MG, Venditti Jr FJet al. Impact of reduced heart rate variability on risk for cardiac events: the Framingham Heart Study. Circulation 1996;94:2850-2855.
17. Liao D, Cai J, Rosamond WD et al. Cardiac autonomic function and incident coronary heart disease a population-based case- cohort study. The ARIC study. Atherosclerosis risk in communities study. Am J Epidemiol 1997;145:696-706.
18. Evrengul H, Tanriverdi H, Kose S et al. The relationship between heart rate recovery and heart rate variability in coronary artery disease. Ann Noninvasive Electrocardiol 2006; 11:154-162.
19. Pagani M, Lombardi F, Guzzetti S et al. Power spectral analysis of heart rate and arterial pressure variabilities as a marker of sympatho-vagal interaction in man and conscious dog. Circ Res 1986;59:178-193.
20. Malliani A, Lombardi F, Pagani M, Cerutti S. Power spectral analysis of cardiovascular variability in patients at risk for sudden cardiac death. J Cardiovasc Electrophysiol 1994;5:274-286.
21. Piccirillo G, Elvira S, Bucca C et al. Abnormal passive head-up tilt test in subjects with symptoms of anxiety power spectral analysis study of heart rate and blood pressure. Int J Cardiol 1997;60:121-131.
22. Lavoie KL, Fleet RP, Laurin C et al. Heart rate variability in coronary artery disease patients with and without panic disorder. Psychiatry Res 2004;128:289-299.
23. Yeragani VK, Berger R, Pohl R et al. Effects of yohimbine on heart rate variability in panic disorder patients and normal controls: a study of power spectral analysis of heart rate. J Cardiovasc Pharmacol 1992;20:609-618.
24. Yeragani VK, Pohl R, Berger R et al. Decreased heart rate variability in panic disorder patients: a study of power-spectral analysis of heart rate. Psychiatry Res 1993;46:89-103.
25. Yeragani VK, Pohl R, Srinivasan K et al. Effects of isoproterenol infusions on heart rate variability in patients with panic disorder. Psychiatry Res 1995;56:289-293.
26. McCraty R, Atkinson M, Tomasino D, Stuppy WP. Analysis of twenty-four hour heart rate variability in patients with panic disorder. Biol Psychol 2001;56:131-150.
27. Guzik P, Piskorski J, Krauze T et al. Correlations between the Poincare plot and conventional heart rate variability parameters assessed during paced breathing. J Physiol Sci 2007; 57:63-71.
28. Shapiro PA, Sloan RP, Bigger Jr JTet al. Cardiac denervation and cardiovascular reactivity to psychological stress. Am J Psychiatry 1994;151:1140-1147.
29. Klein E, Cnaani E, Harel T et al. Altered heart rate variability in panic disorder patients. Biol Psychiatry 1995;37:18-24.
30. Sloan EP, Natarajan M, Baker B et al. Nocturnal and daytime panic attacks: comparison of sleep architecture, heart rate variability, and response to sodium lactate challenge. Biol Psychiatry 1999;45:1313-1320.
31. Cohen H, Benjamin J, Geva AB et al. Autonomic dysregulation in panic disorder and in post-traumatic stress disorder: application of power spectrum analysis of heart rate variability at rest and in response to recollection of trauma or panic attacks. Psychiatry Res 2000;96:1-13.
32. Gorman JM, Sloan RP. Heart rate variability in depressive and anxiety disorders. Am Heart J 2000;140:77-83.
33. Yeragani VK, Tancer M, Uhde T. Heart rate and QT interval variability: abnormal alpha-2 adrenergic function in patients with panic disorder. Psychiatry Res 2003; 121:185-196.
34. Slaap BR, Boshuisen ML, van Roon AM, den Boer JA. Heart rate variability as predictor of nonresponse to mirtazapine in panic disorder: a preliminary study. Int Clin Psychopharmacol 2002; 17:69-74.
35. Carney RM, Freedland KE, Stein PK et al. Change in heart rate and heart rate variability during treatment for depression in patients with coronary heart disease. Psychosom Med 2000;62: 639-647.
36. Tucker P, Adamson P, Miranda R et al. Paroxetine increases heart rate variability in panic disorder. J Clin Psychopharmacol 1997; 17:370-376.
37. Sullivan GM, Kent JM, Kleber M et al. Effects of hyperventilation on heart rate and QT variability in panic disorder pre-and post-treatment. Psychiatry Res 2004;125:29-39.
38. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Patient Edition (SCID-IP, 11/2002 Revision). Washington, DC: American Psychiatric Press; 2002.
39. Guy W. ECDEU Assessment Manual for Psychopharmacology, Revised (DHEW Publication No. ADM 76-338). Washington, DC: US Government Printing Office; 1976.
40. Shear MK, Brown TA, Barlow DH et al. Multicenter collaborative panic disorder severity scale. Am J Psychiatry 1997;154: 1571-1575.
41. Hamilton M. The assessment of anxiety states by rating. Br J Psychiatry 1959;32:50-55.
42. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
43. Dillon DJ, Gorman JM, Liebowitz MR et al. Measurement of lactate-induced panic and anxiety. Psychiatry Res 1987;20: 97-105.
44. Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc 1982;14:377-381.
45. Houtman IL, Bakker FC. The Anxiety Thermometer: a validation study. J Pers Assess 1989;53:575-582.
46. Chambless DL, Caputo GC, Jasin SE et al. The Mobility Inventory for Agoraphobia. Behav Res Ther 1985;23:35-44.
47. Kohn PM, Macdonald JE. The survey of recent life experiences: a decontaminated hassles scale for adults. J Behav Med 1992;15: 221-236.
48. Barlow DH, CraskeMG. Mastery of Your Anxiety and Panic. 3rd ed. New York: Graywind Publications, Inc; 2000.
49. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation 1996;93:1043-1065.
50. Brosschot JF, Van Dijk E, Thayer JF. Daily worry is related to low heart rate variability during waking and the subsequent nocturnal sleep period. Int J Psychophysiol 2007;63:39-47.
51. Martens EJ, Nyklícek I, Szabó BM, Kupper N. Depression and anxiety as predictors of heart rate variability after myocardial infarction. Psychol Med 2008;38:375-383.
52. Lucini D, Riva S, Pizzinelli P, Pagani M. Stress management at the worksite: reversal of symptoms profile and cardiovascular dysregulation. Hypertension 2007;49:291-297.
53. Siepmann M, Grossmann J, Muck-Weymann M, Kirch W. Effects of sertraline on autonomic and cognitive functions in healthy volunteers. Psychopharmacology (Berl) 2003;168:293-298.
54. Yeragani VK, Pohl R, Balon R et al. Effect of imipramine treatment on heart rate variability measures. Neuropsychobiology 1992;26:27-32.
55. Roose SP, Glassman AH, Attia E et al. Cardiovascular effects of fluoxetine in depressed patients with heart disease. Am J Psychiatry 1998;155:660-665.
56. Rasmussen SL, Overo KF, Tanghoj P. Cardiac safety of citalopram: prospective trials and retrospective analyses. J Clin Psychopharmacol 1999;19:407-415.
57. Dusseldorp E, Spinhoven P, Bakker A et al. Which panic disorder patients benefit from which treatment: cognitive therapy or antidepressants? Psychother Psychosom 2007;76:154-161.